Shareholding disclosure

Kenneth C. Griffin

Declared position

3.13%

Threshold

Crossed upwards

Timeline

Published

05.08.2021

Transaction

29.07.2021

Voting rights breakdown

Voting rights acquired3.13%

Voting rights sold1.15%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL8300026

Beneficial owner

Kenneth C. Griffin

Declared address

Kenneth C. Griffin, Chicago, IL

Citadel Securities Financial Trading (Ireland) Designated Activity Company, Dublin, Ireland

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kenneth C. Griffin

Basilea Pharmaceutica AG, Allschwil05.08.2021TAL8300026

Disclosure summary

Kenneth C. Griffin disclosed a holding in Basilea Pharmaceutica AG, Allschwil on the acquisition side, published by SIX Exchange Regulation on 05.08.2021, at 3.13% of voting rights. Notice category: Single shareholder.

Disclosed position

3.13%

Voting rights acquired

Voting rights acquired3.13%

Voting rights sold1.15%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Kenneth C. Griffin disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 05.08.2021.

Publication date05.08.2021

Transaction date29.07.2021

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerKenneth C. Griffin

Declared addressKenneth C. Griffin, Chicago, IL

CategorySingle shareholder

Voting rights acquired3.13%

Voting rights sold1.15%

Below threshold0%

ExchangeXSWX

Notification IDTAL8300026

Conditions

Citadel Securities Financial Trading (Ireland) Designated Activity Company, Dublin, Ireland

Source: SIX Exchange Regulation · Publication date: 05.08.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open